Isgaard and colleagues recruited 22 individuals suffering from congestive HF due to idiopathic dilated cardiomyopathy, ischemic heart disease, or valvular surgery and allocated them to either placebo (n = 11) or GH (n = 11) group. This evidence concerns the gene GH1 and coronary artery disorder.